These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6098315)

  • 1. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes].
    Rybalkin SD; Kurennaia GS; Sobolev AS
    Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS; Rybalkin SD
    Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV; Severin ES
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, characterization and Ca2+ and calmodulin regulation of cyclic nucleotide phosphodiesterases from human placentae of different ages.
    Tertrin-Clary C; Chenut MC; Acker G; De La Llosa P
    Biochem Int; 1989 Jan; 18(1):99-117. PubMed ID: 2541726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the ratio of cyclic nucleotide phosphodiesterase forms in the thymocytes of irradiated mice].
    Rybalkin SD; Sobolev AS
    Radiobiologiia; 1986; 26(2):167-70. PubMed ID: 3010370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
    Hait WN; Weiss B
    Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms.
    Keravis TM; Wells JN; Hardman JG
    Biochim Biophys Acta; 1980; 613(1):116-29. PubMed ID: 6246952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Properties of cyclic nucleotide phosphodiesterase of the rabbit myometrium in various functional states].
    Kurskiĭ MD; Osipenko AA; Prishchepa LA
    Biokhimiia; 1984 Jul; 49(7):1096-102. PubMed ID: 6089916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a cAMP/cGMP phosphodiesterase sensitive to calmodulin [proceedings].
    Ilien B; Landry Y
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B32-B33. PubMed ID: 6155846
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates.
    Grewal J; Karuppiah N; Mutus B
    Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of multiple kinetic forms of soluble cyclic nucleotide phosphodiesterase activity of rat colonic mucosa.
    Craven PA; Neidig M; DeRubertis FR
    Biochim Biophys Acta; 1983 May; 744(3):265-75. PubMed ID: 6303428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of multiple forms of cyclic nucleotide phosphodiesterase from bovine hypothalamus: new factors modulating enzyme activity.
    Galoyan AA; Gurvitz BYa
    Neurochem Res; 1985 Nov; 10(11):1467-81. PubMed ID: 3003614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a liver low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity sensitive to thyroid status.
    Benelli C; Geoffroy V; Fouque F; Lopez S; Desbuquois B
    Endocrinology; 1991 May; 128(5):2376-86. PubMed ID: 1850351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells.
    Epstein PM; Mills JS; Ross CP; Strada SJ; Hersh EM; Thompson WJ
    Cancer Res; 1977 Nov; 37(11):4016-23. PubMed ID: 198126
    [No Abstract]   [Full Text] [Related]  

  • 19. General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.
    Strada SJ; Martin MW; Thompson WJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():13-29. PubMed ID: 6326518
    [No Abstract]   [Full Text] [Related]  

  • 20. [The process of cyclic adenosine-3',5'-monophosphate phosphodiesterase activation by 2',5'-oligoadenylate].
    Tunitskaia VL; Itkes AV; Kochetkova MN; Severin ES
    Biokhimiia; 1983 Oct; 48(10):1721-5. PubMed ID: 6315087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.